The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Michael Schug, an award-winning communicator, is the communications manager at the Indiana University Melvin and Bren Simon Cancer Center. In this role, he promotes the important research generated by the nearly 240 research members of the IU Simon Comprehensive Cancer Center.
INDIANAPOLIS — An Indiana University cancer researcher has identified eight new genomic regions that increase a person’s risk for skin cancer. Jiali Han, Ph.D., and colleagues discovered eight new loci—locations on a person’s genome—that are susceptible to the development of squamous cell skin cancer. Han is the Rachel Cecile Efroymson Professor in Cancer Research at […]
INDIANAPOLIS — A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute “Cancer Moonshot” grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia. The research promises to achieve more effective, better targeted and less toxic therapies for […]
INDIANAPOLIS — On a night when Chuck Pagano returned to Indianapolis, Colts owner Jim Irsay pledged $1 million to cancer research in his former coach’s honor, helping to raise more than $1.8 million to support scientists at the Indiana University Melvin and Bren Simon Cancer Center. Colts Chief Operating Officer Pete Ward made the announcement […]
INDIANAPOLIS—A $1.2 million Department of Defense grant has been awarded to an Indiana University School of Medicine physician whose research explores a cascade of events that decreases quality of life and treatment responses for patients with metastatic bone cancer. Theresa Guise, MD, hopes to understand the role of the tumor-bone microenvironment on glucose metabolism and […]
INDIANAPOLIS — Indiana University School of Medicine cancer researchers who have been working to lessen the debilitating side effects caused by chemotherapy have been awarded $2.3 million to continue their studies. Jill Fehrenbacher, PhD, and Mark Kelley, PhD, are recipients of the five-year grant (1R01CA231267) from the National Cancer Institute, which will enable them to […]
Indiana University School of Medicine radiology researchers will recruit 3,000 women to participate in TMIST, a nationwide study comparing the two most common technologies used for breast cancer screening. Tomosynthesis, also known as three-dimensional or 3-D mammography screening, will be compared with 2-D or conventional mammography in a study conducted by the National Cancer Institute […]
A leading pediatrician will be the inaugural Chuck and Tina Pagano Scholar at Indiana University School of Medicine. Rachel Katzenellenbogen, MD, will hold that title as well as associate professor of pediatrics. She is also a member of the Cancer Prevention and Control research program at the Indiana University Melvin and Bren Simon Cancer Center and […]
An Indiana University cancer researcher will study why high-risk patients eligible for lung cancer screening are not referred in greater numbers for the non-invasive procedure. Lisa Carter-Harris, PhD, has been awarded $100,000 by the American Lung Association for a two-year behavioral study of primary care clinicians to identify barriers associated with low referral rates for […]
INDIANAPOLIS – Restricting protein from a cancer patient’s diet may enhance the response to immunotherapy, according to an Indiana University cancer physician researcher. Roberto Pili, MD, the Robert Wallace Miller Professor of Oncology at Indiana University School of Medicine and a researcher at the Indiana University Melvin and Bren Simon Cancer Center, and colleagues have […]